Optalert is pleased to announce the availability of its latest driver monitoring software solution.  Providing the most advanced measure of drowsiness & attentiveness in the automotive market, this gives Tier 1’s the ability to embed the technology directly into their driver monitoring systems (DMS). The patented Optalert Johns Drowsiness Scale (JDS) provides a continuous numerical...

Latest News Today, Melbourne based Medtech company, Optalert Australia, were announced as the recipient of the Australian Government – Automotive Innovation Lab Access Grant (AILAG).   The grant will be used to advance the development of the Optalert Video Automotive technology solution for the objective, early prediction of drowsiness and attentiveness monitoring. The project aims to...

The Consumer Electronics Show (CES2019) dazzled participants once again with glimpses of technologies and products on the horizon for the future.  With over 180,000 attendees from 150 different countries, circulating over 11 venues throughout Las Vegas. Optalert’s key conversations at this year’s event included autonomous vehicles, enhanced ‘early warning’ drowsiness and distraction features, and AI...

Optalert is pleased to introduce the BlinQ system for the measurement of drowsiness or wakefulness in clinical trials. Optalert uses advanced patented algorithms to determine the exact drowsiness or wakefulness of a subject.  By applying Artificial Intelligence techniques and machine learning Optalert has been able to objectively quantify drowsiness or wakefulness.  Utilising the Johns Drowsiness Scale (JDS), Optalert’s future-proofed...